Androgen deprivation therapy-related fracture risk in prostate cancer: an insurance claims database study in Japan
Journal of Bone and Mineral Metabolism · 2024-03 · 42 (2) · 223-232
DOI: 10.1007/s00774-024-01497-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 17.03.2024. Verfasst von Hisashi Matsushima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tokyo Metropolitan Police Hospital, 4-22-1 Nakano, Nakano-ku, Tokyo, 164-8541, Japan. hmatsu53@me.com. Hauptthemen laut MEDLINE: Osteoporotic Fractures, Prostatic Neoplasms, Insurance. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daiichi-Sankyo.
Abstract (Originalsprache)
Introduction
Androgen deprivation therapy (ADT) is widely used for the treatment of prostate cancer. ADT is associated with reduced bone density leading to an increased risk of osteoporotic fracture. The objective of this retrospective cohort study was to quantify fracture risk in men treated with ADT for prostate cancer in real-world practice in Japan. Materials and methods Data were extracted from the Japanese Medical Data Vision (MDV) database. Men initiating ADT for treatment of prostate cancer between April 2010 and March 2021 were identified and matched to a cohort of prostate cancer patients not taking ADT using a propensity score. Fracture rates were estimated by a cumulative incidence function and compared between cohorts using a Cox cause-specific hazard model. Information was extracted on demographics, comorbidities and bone densitometry.
Results
30,561 men with PC starting ADT were matched to 30,561 men with prostate cancer not treated with ADT. Following ADT initiation,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Tokyo Metropolitan Police Hospital, 4-22-1 Nakano, Nakano-ku, Tokyo, 164-8541, Japan. hmatsu53@me.com.
- Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Primary Medical Science Department, Medical Affairs Division, Japan Business Unit, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
- Data Intelligence Department, Global DX, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
- Putnam PHMR, Kraków, Poland.
- Tokushima University, Tokushima, Japan.
Förderung
- Daiichi-Sankyo
Zitieren
APA
Matsushima, H., Taguchi, T., Kodama, S., Okubo, N., Saito, K., Jabłońska, K., Fukumoto, S., & Matsumoto, T. (2024). Androgen deprivation therapy-related fracture risk in prostate cancer: an insurance claims database study in Japan. Journal of Bone and Mineral Metabolism, 42(2), 223-232. https://doi.org/10.1007/s00774-024-01497-4
Vancouver
Matsushima H, Taguchi T, Kodama S, Okubo N, Saito K, Jabłońska K, et al. Androgen deprivation therapy-related fracture risk in prostate cancer: an insurance claims database study in Japan. Journal of Bone and Mineral Metabolism. 2024;42(2):223-232. doi:10.1007/s00774-024-01497-4
BibTeX
@article{Matsushima2024,
author = {Matsushima, Hisashi and Taguchi, Tetsuya and Kodama, Sho and Okubo, Naoki and Saito, Kengo and Jabłońska, Katarzyna and Fukumoto, Seiji and Matsumoto, Toshio},
title = {Androgen deprivation therapy-related fracture risk in prostate cancer: an insurance claims database study in Japan},
journal = {Journal of Bone and Mineral Metabolism},
year = {2024},
volume = {42},
number = {2},
pages = {223--232},
doi = {10.1007/s00774-024-01497-4}
}
EUVIMED